The Diagnostic Role in AMR

The Diagnostic Role in AMR

Product not yet rated

Recorded On: 04/26/2023


This session was part of the Sepsis Alliance AMR Conference 2023.

Diagnostics play an important role in preventing the misuse of antibiotics because they enable healthcare professionals to select the most effective treatment for a condition. This helps reduce the risk of antibiotic resistance (AMR). Additionally, the time delay in starting appropriate antibiotic treatment can be a matter of life or death for serious infections, like the ones that can lead to sepsis. Rapid diagnostics play a crucial role in identifying the infectious agent, as well as any potential resistance to antibiotics. In this session, the presenter will review diagnostic stewardship and its importance for limiting the spread of AMR and optimizing patient outcomes. 

Learning Objectives: 

At the end of the session, the learner should be able to:

  • Identify current trends in antimicrobial resistance;
  • Review the role of antimicrobial stewardship in combatting antimicrobial resistance;
  • Examine appropriate use of rapid diagnostics in infection detection.

Target Audience: 

Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

Edward J. Septimus, MD, FIDSA, FACP, FSHEA

Senior Lecturer, Department of Population Medicine

Harvard Medical School

Ed Septimus, MD, FIDSA, FACP, FSHEA, received his medical degree from Baylor College of Medicine in Houston in 1972.  He is board certified in both internal medicine and infectious diseases. after completing his postgraduate training in internal medicine and infectious diseases also at Baylor College of Medicine in Houston. 

Dr. Septimus was Vice President of Research and Infectious Diseases at HCA Healthcare until 2018. Prior to HCA, he was the Medical Director of Infectious Diseases and Occupational Health for Memorial Hermann Healthcare System. He has served on the Board of Directors of the Infectious Diseases Society of America (IDSA) and was on the IDSA Antimicrobial Resistance Committee, the SHEA Antimicrobial Stewardship Committee, and the IDSA Quality Measurement Committee. He is now on the IDSA Sepsis Task Force. Dr. Septimus was chair of the Healthcare Safety Advisory Committee for the Texas Department of State Health Services from 2018-2021 and was the first recipient of the IDSA Watanakunakorn Clinician Award. He was also awarded the John S Dunn Sr. Outstanding Teacher Award. Until the end of 2021, Dr. Septimus was co-chair of the NQF Patient Safety Steering Committee.  He is now vice chair of the NQF Consensus Standards Approval Committee and holds faculty positions as Adjunct Professor at Texas A&M College of Medicine, Senior Lecturer Department of Population Medicine Harvard Medical School, and as Adjunct Professor of Medicine Houston Methodist Research Institute/Weill Cornell. He has published over 140 articles and chapters.

Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.0 contact hours.

Other healthcare professionals will receive a certificate of attendance for 0.75 contact hours.

Medical Disclaimer

The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.

Components visible upon registration.